HG Pharma SRL
0.9 FTEHG Pharma reported total assets of €4.87m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Apr 2026), with 0.9 full-time equivalent.
The score of HG Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +17 % Total assets +89 % Headcount (avg FTE) +800 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
HG Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 144,349 € | ||||
| Equity | 427,572 € | ||||
| Cash | 30,149 € | ||||
| EBITDA | 288,387 € | ||||
| Total assets | €4.87m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Apr 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
HG Pharma's financial analysis
- Solvency8.8%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of HG Pharma
HG Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0832.287.120
- VAT number
- BE0832287120
- Peppol
- Registered · 0208:0832287120 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 2010
- Registered office
- 1341 Ottignies-Louvain-la-Neuve
- Size
- Micro · 0.9 FTE
- Latest accounts
- 2025 · filed on 27 Apr 2026
- Activity
- Activities of holding companies (NACE 64210)
HG Pharma (SRL) has been based in Ottignies-Louvain-la-Neuve since 2010, active in: activities of holding companies. For 2025, it reports a net profit of 144,349 € and equity of 427,572 €; its revenue is not published. With 0.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 8.8%, below the median of its sector (46.9%).
Companies similar to HG Pharma
Companies in the same business, of comparable size and area, outside its group.
- CBinvest Activities of holding companies Mechelen · balance sheet €4.88m
- Lambrecht Yves Patrimonium Compagnie Activities of holding companies Kortrijk · balance sheet €4.54m
- Vandaele Vast Goed Activities of holding companies Veurne · balance sheet €4.55m
- M.D.M. Activities of holding companies Eeklo · balance sheet €4.04m
- M.B. 19 Activities of holding companies Ciney · balance sheet €3.94m
- Indubema Activities of holding companies Arendonk · balance sheet €5.91m
- Capnor Co-Investments V Activities of holding companies Lasne · balance sheet €3.88m
- Electronic Associates Activities of holding companies Keerbergen · balance sheet €3.05m
Frequently asked questions about HG Pharma
What is the revenue of HG Pharma?
HG Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of HG Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0832287120 for HG Pharma, if the company is VAT-registered. Its company number (CBE) is 0832.287.120.
Where is the registered office of HG Pharma?
According to the CBE register, the registered office of HG Pharma is in 1341 Ottignies-Louvain-la-Neuve.
What is the equity of HG Pharma?
At the close of the 2025 financial year, the equity of HG Pharma amounts to 427,572 €, a solvency of 8.8% of total assets.
How many people work at HG Pharma?
0.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages HG Pharma?
The register lists 2 active mandates at HG Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of HG Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →